NasdaqGS - Delayed Quote USD
Vor Biopharma Inc. (VOR)
0.2200
-0.0095
(-4.14%)
At close: 4:00:00 PM EDT
0.2141
-0.01
(-2.68%)
After hours: 5:32:18 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 56,166,260 | 6 |
| Sales | 15,115 | 3 |
| Net Shares Purchased (Sold) | 56,151,145 | 9 |
| Total Insider Shares Held | 39.85M | -- |
| % Net Shares Purchased (Sold) | -344.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ATTAR EYAL C Officer | Sale at price 1.42 per share. | Direct | 3,162 | Feb 13, 2025 |
| ATTAR EYAL C Officer | Sale at price 1.37 per share. | Direct | 3,499 | Feb 10, 2025 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| CHOI HAN WOOK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 3, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Dec 30, 2024 |
| REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.19 per share. | Indirect | 46,379,180 | Dec 30, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.25 per share. | Direct | 12,918 | Dec 27, 2024 |
| ATTAR EYAL C Officer | Sale at price 1.39 per share. | Direct | 20,357 | Jun 3, 2024 |
| ANG ROBERT M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| ATTAR EYAL C Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| CHAKRABORTY TIRTHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
| JORGENSEN NATHAN D. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2024 |
Related Tickers
GBIO Generation Bio Co.
0.3910
-8.02%
CGEM Cullinan Therapeutics, Inc.
8.98
-0.55%
ALXO ALX Oncology Holdings Inc.
0.5485
+2.75%
OVID Ovid Therapeutics Inc.
0.3188
-0.72%
MRSN Mersana Therapeutics, Inc.
0.3804
-6.54%
STRO Sutro Biopharma, Inc.
0.8268
-1.52%
ATHA Athira Pharma, Inc.
0.3212
-6.76%
RLMD Relmada Therapeutics, Inc.
0.7665
-4.00%
PCSA Processa Pharmaceuticals, Inc.
0.4000
+16.45%
TNFA TNF Pharmaceuticals, Inc.
0.1643
-6.70%